Lower hemoglobin concentration decreases time to death in severely anemic patients for whom blood transfusion is not an option

Journal of Trauma and Acute Care Surgery

Volumn 88, Issue 6, 2020, Pages 803-808

  Guinn, Nicole R ^a   Cooter, Mary L ^a   Weiskopf, Richard B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia; blood refusal; transfusion

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ALL CAUSE MORTALITY; ANEMIA; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEMATOLOGIC DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MALNUTRITION; MEDICAL HISTORY; MORTALITY RATE; MORTALITY RISK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; NORTH CAROLINA; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; RELIGION; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT REFUSAL;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PROPORTIONAL HAZARDS MODELS; RELIGION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT REFUSAL;

EID: 85085532000     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000002632     Document Type: Article

References (23)

1. Weiskopf RB, Viele MK, Feiner J,. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA. 1998; 279 (3): 217-221.
2. Fakhry SM, Fata P,. How low is too low? Cardiac risks with anemia. Crit Care. 2004; 8 (Suppl 2): S11-S14.
3. Weiskopf RB, Kramer JH, Viele M, Neumann M, Feiner JR, Watson JJ, Hopf HW, Toy P,. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 2000; 92 (6): 1646-1652.
4. Weiskopf RB, Feiner J, Hopf HW, Viele MK, Watson JJ, Kramer JH, Ho R, Toy P,. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology. 2002; 96 (4): 871-877.
5. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340 (6): 409-417.
6. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, Reeves BC,. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015; 372 (11): 997-1008.
7. Villanueva C, Colomo A, Bosch A,. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013; 368 (1): 11-21.
8. Carson JL, Terrin ML, Noveck H,. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365 (26): 2453-2462.
9. Hajjar LA, Vincent JL, Galas FR,. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304 (14): 1559-1567.
10. Robertson CS, Hannay HJ, Yamal JM, Epo Severe TBI Trial Investigators. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014; 312 (1): 36-47.
11. Guinn NR, Cooter ML, Villalpando C, Weiskopf RB,. Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. Transfusion. 2018; 58 (10): 2290-2296.
12. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, Juhl A,. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion. 2014; 54 (10 Pt 2): 2688-2695; quiz 2687.
13. Carson JL, Noveck H, Berlin JA, Gould SA,. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002; 42 (7): 812-818.
14. Tobian AA, Ness PM, Noveck H, Carson JL,. Time course and etiology of death in patients with severe anemia. Transfusion. 2009; 49 (7): 1395-1399.
15. Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi M, Greenburg AG,. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg. 2010; 110 (3): 685-693.
16. Weiskopf RB, Beliaev AM, Shander A, Guinn NR, Cap AP, Ness PM, Silverman TA,. Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. Transfusion. 2017; 57 (1): 207-214.
17. Jahr JS, Guinn NR, Lowery DR, Shore-Lesserson L, Shander A,. Blood Substitutes and Oxygen Therapeutics: A Review. Anesth Analg. 2019.
18. Mackenzie CF, Dubé GP, Pitman A, Zafirelis M,. Users guide to pitfalls and lessons learned about HBOC-201 during clinical trials, expanded access, and clinical use in 1,701 patients. Shock. 2019; 52 (1S Suppl 1): 92-99.
19. Levien LJ,. South Africa: clinical experience with Hemopure. ISBT Sci Ser. 2006; 1 (1): 167-173.
20. Mer M, Hodgson E, Wallis L,. Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients. Transfusion. 2016; 56 (10): 2631-2636.
21. Contal C, O'Quigley J,. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data An. 1999; 30 (3): 253-270.
22. Weiskopf RB, Silverman TA,. Balancing potential risks and benefits of hemoglobin-based oxygen carriers. Transfusion. 2013; 53 (10): 2327-2333.
23. Viele MK, Weiskopf RB,. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion. 1994; 34 (5): 396-401.